Get started
Award

847422

Funder: Horizon 2020
Funded outputs count: 9
Funder award ID: 847422
OpenAlex ID: G7917616632
Prioritized barriers to implementation of personalized immunotherapy for sepsis patients
2026 · Nynke Bos, Julie E. M. Swillens, et al. · Implementation Science Communications · 1
PDF
Can metaphors in patient information materials improve comprehension and attitudes regarding innovative treatment? The case of personalized immunotherapy for sepsis
2025 · Nynke Bos, W. Gudrun Reijnierse, et al. · Patient Education and Counseling
Towards personalized medicine: a scoping review of immunotherapy in sepsis
2024 · Marleen A. Slim, Niels van Mourik, et al. · Critical Care · 67
PDF
Inflammatory subphenotypes previously identified in ARDS are associated with mortality at intensive care unit discharge: a secondary analysis of a prospective observational study
2024 · Marleen A. Slim, Rombout B. E. van Amstel, et al. · Critical Care · 6
Stratification of Atherosclerosis based on Plasma Metabolic States
2023 · Yuval Menaker, Inge van den Munckhof, et al. · The Journal of Clinical Endocrinology & Metabolism · 9
PDF
Distinct gene programs underpinning disease tolerance and resistance in influenza virus infection
2022 · Ofir Cohn, Gal Yankovitz, et al. · Cell Systems · 27
An integrative model of cardiometabolic traits identifies two types of metabolic syndrome
2021 · Amit Frishberg, Inge van den Munckhof, et al. · eLife · 7
Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis
2020 · George Dimopoulos, Quirijn de Mast, et al. · Cell Host & Microbe · 245
PDF
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
2020 · Evangelos J. Giamarellos-Bourboulis, Mihai G. Netea, et al. · Cell Host & Microbe · 2,043
PDF
Year
Topic